FDA establishment 3008477155, Bedford, Massachusetts, United States. Part of Ocular Therapeutix's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations.
FY2018 to FY2027 to date; 0 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
Inspections citing each reference
| Nov 9, 2023 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Feb 11, 2016 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Mar 11, 2015 | Devices · Compliance: Devices | 1 cited reference
| Voluntary Action Indicated (VAI) |
| Jun 3, 2013 | Devices · Bioresearch Monitoring | None posted | No Action Indicated (NAI) |
| Apr 26, 2013 | Devices · Compliance: Devices | None posted | Voluntary Action Indicated (VAI) |
| Apr 6, 2012 | Devices · Compliance: Devices | 1 cited reference
| Voluntary Action Indicated (VAI) |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections. FDA Data Dashboard, warning letters and enforcement reports